Anzeige
Mehr »
Login
Donnerstag, 15.04.2021 Börsentäglich über 12.000 News von 660 internationalen Medien
Relay Medical: Das sind gewaltige Neuigkeiten! Die Lizenz zum Millionen scheffeln?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PharmaTimes

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiPfizer, Myovant begin dosing in relugolix contraceptive study
MiGilead's Trodelvy scores accelerated approval in advanced bladder cancer
MiNICE publishes new guidance on chronic pain management
MiUK trial evaluating 'mix and match' COVID-19 vaccine regimens expanded
DiAntibiotic Research UK launches small research grants programme
DiExperts call for advanced radiotherapy funding to address COVID-19 cancer care backlog
DiInhaled asthma drug accelerates recovery from COVID-19
DiFour medicines accepted for use by NHS Scotland
MoUS approval for first AI device to help detect colon cancer
MoC4X Discovery agrees licensing deal with Sanofi
MoEarly promise for new immunotherapy combo in brain cancer
MoFarxiga fails to achieve statistical significance in COVID-19 trial
MoTake the next step into CROY 2021
FrEU nod for new formulation of Biogen's Tysabri
FrNICE 'no' for Opdivo/Yervoy lung cancer combo
FrHuman trials for world's first AI-designed immuno-oncology drug
FrLilly, Incyte's Olumiant fails in COVID-19 trial
08.04.Achilles Therapeutics' US IPO closed with proceeds of $175m
08.04.Novartis bags EU, UK licences for MS therapy Kesimpta
08.04.Benefits of AZ vaccine outweigh risks, says MHRA
08.04.Coronavirus infections drop but R number remains at 1
07.04.Novartis UK announces further HRT patch stock issues
07.04.Nationwide launch for pioneering fertility study
07.04.Artios, Novartis form cancer therapies collaboration
07.04.Fund opens to boost UK life sciences manufacturing